Results 21 to 30 of about 238 (95)
Background: Detection of the BCR‐ABL1 fusion transcript in CML patients using RT‐qPCR allows sensitive monitoring of disease levels (minimal residual disease, MRD), which is important for determining prognosis and making treatment decisions. To interpret MRD results correctly in respect to data from clinical trials, it is necessary to report data as IS,
J. Petersen, G.W. Novotny
wiley +1 more source
Background: With the advent of tyrosine kinase inhibitors (TKIs), patients with chronic myeloid leukemia (CML) have a life expectancy similar to those of age‐ and sex‐matched healthy population. Nevertheless, patients receiving TKIs report chronic adverse events, some of which may be associated with severe symptoms including fatigue, edema, muscle ...
T. Toptas +6 more
wiley +1 more source
Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020
HemaSphere, Volume 4, Issue S1, Page 1-1168, June 2020.
wiley +1 more source
Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells. [PDF]
Al-Rawashde FA +5 more
europepmc +1 more source
Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia. [PDF]
Lahlil R +5 more
europepmc +1 more source

